3.28 USD
↘ 0.29 (8.12%)AT CLOSE (11:59 AM EDT)
Clene Inc. Common Stock
CLNNNASDAQ • USD
3.29
↗ 0.01 (0.43%)
POST MARKET (AS OF 04:14 PM EDT)
Post Market
AS OF 04:14 PM EDT
3.29
↗ 0.01 (0.43%)
Market: OPEN
Shares of Clene Inc. Common Stock (CLNN) are trading at $3.29. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (159.5%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Sep 11, 2026.
Open?$3.57
High?$3.72
Low?$3.26
Prev. Close?$3.57
Volume?139.5K
Avg. Volume?96.1K
VWAP?$3.46
Rel. Volume?1.45x
Bid / Ask
Bid?$2.75 × 100
Ask?$4.02 × 100
Spread?$1.27
Midpoint?$3.39
Valuation & Ratios
Market Cap?45.9M
Shares Out?12.8M
Float?8.3M
Float %?70.3%
P/E Ratio?N/A
P/B Ratio?-1.85
EPS?-$3.08
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Themes
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50
SALT LAKE CITY, UT 84121
Phone: 801-676-9695
SALT LAKE CITY, UT 84121
Phone: 801-676-9695
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?0
Momentum?50
Short Sent.?48
Piotroski F-Score?2/9Weak
Altman Z-Score?-21.87Distress
Confidence?58%Low
Short InterestVery High
Short % of Float?11.66%High
Short Interest?965.6K
Days to Cover?17.7
Free Float8.3M
Avg Daily Volume54.7K
Settlement Date2026-08-31
Financial Health
Current Ratio?3.07Strong
Quick Ratio?3.07Strong
Cash Ratio?1.99Strong
Debt/Equity?-0.76Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-1.85CHEAP▾
S&P97
P/S?232.84HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-2.9CHEAP▾
S&P97
EV/Sales?278.79HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?159.5%STRONG▾
Peers50
S&P97
ROA?-171.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-15947000
Enterprise Value?$54.9M
Fundamentals ratios updated end of day